Her works that earned her a number of literary awards are: Hik
dil hazaar arman (1957); Shishe ji dil (1963); Hayaati hotan re (1979); Waqt, vithyoon, vichhotiyoon (1988); Aarsi-a-aado (1992); Pakhin ji preet (1998); Samund ain kinaro (2004); Aukha pandh pyaar jaa (2010); Compilation: Murk ain mamta (1973);Varan me gul (1993); lntezaar (2008).
(University of Alberta), for introducing me to the Kluane community and shaping this project with me; to Dr.
and an anonymus reviewer kindly provided helpful comments on an earlier draft of this note.
"Understanding the traditional knowledge of the northern Aboriginal people allows an opportunity to capacity build stronger community-based monitoring of the environment in the north," said David Hik
, director of the Canadian IPY Secretariat and a professor in the Department of Biological Sciences at the University of Alberta.
De forma geral, as principais fontes de variacao associadas a extracao dos pigmentos clorofilianos incluem a natureza, polaridade e grau de pureza do solvente (RITCHIE, 2008), a temperatura e o tempo de incubacao (TAIT & HIK
, 2003), e as equacoes utilizadas para calcular as concentracoes das clorofilas (PORRA, 2002).
Hikma's ordinary shares trade on the London Stock Exchange (LSE) under the symbol HIK
His first selection comes from Danish Division One with HIK
taking on bottom- placed underdogs Skjold, who have only secured one point in five games.
Our local MPs are no w enjo ying their salary increases and hik
es in their pensions and I hope t hey have spent well in Harr ods prior to their return to the Nort h West.
(Ala = Alabama Creek, Aus = Austin Branch, Cam = Camp Creek, CB = Cochino Bayou, Hak = Hackberry Creek, Hag = Hager Creek, Hik
= Hickory Creek, Lyn = Lynch Creek, Pin = Piney Creek, San = Sandy Creek).
Signed from HIK
Copenhagen this week, the 28-year-old was commanding in his first game in the Football League.
Release date- 05082019 - Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK
) (NASDAQ Dubai: HIK
) (OTC: HKMPY) (rated Ba1/stable Moody's and BB+/positive S&P), the multinational generic pharmaceutical company, today announces that Dr Shahin Fesharaki joins the company as Chief Scientific Officer and Global Head of Research & Development (R&D).
Contract notice: Establishment of new driving lines for the service to the hpk ratingen and hik